Evidence map›Paper›PMID 25303370›Full record

Trial reportBlood cancer journal2014

Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphoma.

F Liao, Y-C Hsu, S-H Kuo, Y-C Yang, J-P Chen, P-N Hsu, C-W Lin, L-T Chen, A-L Cheng, C S J Fann and 2 more

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Blood cancer journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. [Characteristics of Gastric Mucosa-associated Lymphoid Tissue Lymphoma in Korea].The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2024
    Review
  3. Article
  4. The role of IL-22 in cancer.Medical oncology (Northwood, London, England) · 2024
    Review
  5. Review
  6. Role of Gastric Microorganisms Other thanBioMed research international · 2022
    Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

F LiaoInstitute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
Y-C Hsu1] Department of Internal Medicine, E-Da Hospital/I-Shou University, Kaohsiung, Taiwan [2] Center for Database Research, E-Da Hospital/I-Shou University, Kaohsiung, Taiwan.
S-H KuoDepartment of Oncology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Y-C YangInstitute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
J-P ChenInstitute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
P-N HsuDepartment of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
C-W LinDepartment of Pathology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
L-T ChenNational Institute of Cancer Research, National Health Research Institute, Tainan, Taiwan.
A-L ChengDepartment of Oncology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
C S J FannInstitute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
J-T LinDepartment of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
M-S WuDepartment of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
National Taiwan University Hospital · TWInstitute of Biomedical Sciences, Academia Sinica · TWI-Shou University · TWNational Health Research Institutes · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic Helicobacter pylori-stimulated immune reactions determine the pathogenesis of gastric mucosa-associated lymphoid tissue (MALT) lymphoma. We aimed to explore the genetic predisposition to this lymphoma and its clinical implication. A total of 68 patients and 140 unrelated controls were genotyped for 84 single-nucleotide polymorphisms in genes encoding cytokines, chemokines and related receptors that play important roles in T cell-mediated gastrointestinal immunity. Five genotypes in IL-22, namely CC at rs1179246, CC at rs2227485, AA at rs4913428, AA at rs1026788 and TT at rs7314777, were associated with disease susceptibility. The former four genotypes resided in the same linkage disequilibrium block (r(2)=0.99) that conferred an approximately threefold higher risk. In vitro experiments demonstrated that co-culturing peripheral mononuclear cells or CD4(+) T cells with H. pylori stimulated the secretion of interleukin-22 (IL-22), and that IL-22 induced the expression of antimicrobial proteins, RegIIIα and lipocalin-2, in gastric epithelial cells. Furthermore, patients with gastric tissue expressing IL-22 were more likely to respond to H. pylori eradication (14/22 vs 4/19, P<0.006). We conclude that susceptibility of gastric MALT lymphoma is influenced by genetic polymorphisms in IL-22, the product of which is involved in mucosal immunity against H. pylori and associated with tumor response to H. pylori eradication.

Indexed as

Gene Expression Regulation, NeoplasticGenetic Predisposition to DiseaseHelicobacter InfectionsHelicobacter pyloriInterleukinsLymphoma, B-Cell, Marginal ZoneNeoplasm ProteinsPolymorphism, Single NucleotideStomach NeoplasmsCD4-Positive T-LymphocytesCell Line, TumorFemaleHumansInterleukin-22MaleInterleukin-22InterleukinsNeoplasm Proteins

Identifiers

PMID25303370
PMCPMC4220648
OpenAlexW2017390491

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.